Is this the swan song of endovascular brachytherapy?

Radiotherapy and Oncology

Volumn 82, Issue 1, 2007, Pages 1-4

  Van Limbergen, Erik ^a   Trepuraneni, Prabhakar ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

BRACHYTHERAPY; CORONARY ARTERY OBSTRUCTION; COST EFFECTIVENESS ANALYSIS; DRUG ELUTING STENT; EDITORIAL; ELECTRON THERAPY; ENDOVASCULAR SURGERY; GAMMA RADIATION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION;

BRACHYTHERAPY; CORONARY RESTENOSIS; DRUG ADMINISTRATION ROUTES; HUMANS; RADIATION ONCOLOGY; STENTS;

EID: 33846370540     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.11.012     Document Type: Editorial

References (32)

1. Boettcher H.D., Schopohl B., Liermann D., et al. Endovascular irradiation: a new method to avoid recurrent stenosis after stent implantation in peripheral arteries technique and preliminary results. Int J Radiat Oncol Biol Phys 29 (1994) 183-186
2. Condado J.A., Waksman R., Gurdiel O., et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 96 (1997) 727-732
3. Holmes DR, Teirstein P, Satler L, et al. for the SISR investigators. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents. JAMA 2006;295:1264-73.
4. Kirisits C., Georg D., Wexberg P., Pokrajac B., Glogar D., and Pötter R. Determination and application of the reference isodose legth (RIL) for commercial endovascular brachytherapy devices. Radiother Oncol 64 (2002) 309-315
5. Kirisits C., Stemberger A., Pokrajac B., Glogar D., Pötter R., and Georg D. Clinical quality assurance for endovascular brachytherapy devices. Radiother Oncol 71 (2004) 91-98
6. Kirisits C., Wexberg P., Gottsauner-Wolf M., et al. Dose-volume histograms based on serial intravascular ultrasound: a calculation model for radioactive stents. Radiother Oncol 59 (2001) 329-337
7. Marijnissen J.P., Coen V.L., Van der Giession W.J., de Pan C., Serruys P.W., and Levendag P.C. Optimal source position for irradiation of coronary bifurcations in endovascular brachytherapy with catheter based beta or iridium-192 sources. Radiother Oncol 71 (2004) 99-108
8. Minar E., Pocrajac B., Maca T., et al. Brachytherapy for prophylaxis of restenosis after long segment femoropopliteal angioplasty: pilot study. Radiology 208 (1998) 173-179
9. Minar E., Pocrajac B., Maca T., et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomised study. Circulation 102 (2000) 2694-2699
10. Murphy S.A., and Gibson C.M. Drug eluting stent late thrombosis meta-analysis. American College of Cardiology's Cardiosource (2006)
11. Leon M.B., Teirstein P.S., Moses J.W., et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 344 (2001) 250-256
12. Pokrajac B., Pötter R., Wolfram R.M., et al. Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 multicenter study. Radiother Oncol 74 (2005) 3-9
13. 192Ir HDR brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and rist factors analysis. Int J Radiat Oncol Biol Phys 48 (2000) 923-931
14. Pokrajac B., Schmid R., Kirisits C., et al. possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study. Radiother Oncol 63 (2002) 97-102
15. Popma JJ, Suntharalingam M, Lansky A, et al. for the Stents and Radiation Therapy (START) investigators. Randomised trial of 90 Sr/90 Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002;106:1090-6.
16. Pötter R., Van Limbergen E., Dries W., et al. Recommendations of the EndoVAscular GEC ESTRO Working Group (EVA GEC ESTRO): prescribing, recording, and reporting in endovascular brachytherapy. Quality assurance, equipment, personal and education. Radiother Oncol 59 (2001) 339-360
17. Raizner A.E., Oesterle S.N., Waksman R., et al. Inhibition of restenosis with beta-emitting radiotherapy. Report of the proliferation reduction with vascular energy trial (PREVENT). Circulation 102 (2000) 951-958
18. Schukro C., Syefa B., Kirisits C., et al. Randomized comparison between intracoronary β-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. Radiother Oncol 82 (2007) 18-23
19. Schmid R., Kirisits C., Syeda B., et al. Evaluation of geographic miss in endovascular brachytherapy of the coronaries. A new method of assessment. Recommendations for determining the planning target length to avoid geographic miss. The Vienna Experience. Radiother Oncol 71 (2004) 311-318
20. Stone G.W., Ellis S.G., P'Shaughnessy C.D., et al. Paclitaxel-eluting stents versus vascular brachytherapy for in-stent restenosis within bare-metal stents. The TAXUS V ISR randomised trial. JAMA 295 (2006) 1253-1263
21. Tierstein P.S., Massullo V., Jani S., et al. Two-year follow-up after catheter-based radiotherapy to inhibit coronary restenosis. Circulation 99 (1999) 243-247
22. Thomas M.R. Brachytherapy: here today, gone tomorrow?. Heart 91 Suppl. (2005) 32-34
23. Van Limbergen E., Poetter R., Dries W., Kirisits C., Levendag P., and Popowski Y. Organization of the multidisciplinary practice of Endovascular brachyherapy: the view of the EVA GEC-ESTRO Working Group. Vascular Radiotherapy Monitor 4 (2002) 30-35
24. Verin V., Popowski Y., Urban P., et al. Intra-arterial beta-irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model. Circulation 91 (1995) 2284-2290
25. Verin V., Popowski Y., de Bruyne B., et al. Endoluminal beta-radiation therapy for the preservation of coronary restenosis after balloon angioplasty. N Engl J Med 344 (2001) 243-250
26. Waksman R., Robinson K.A., Crocker I.R., et al. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. A possible role for radiation therapy in restenosis prevention. Circulation 91 (1995) 1533-1539
27. Waksman R. Late thromboses after radiation: sitting on a bomb. Circulation 100 (1999) 780-782
28. Waksman R., Bhargava B., White L., et al. Intra-coronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 101 (2000) 1895-1998
29. Waksman R., White R.L., Chan R.C., et al. Intra-coronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 101 (2000) 2165-2171
30. Waksman R., Laird J.R., Jurkovitz C.T., et al. Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial. J Vasc Interv Radiol 12 (2001) 915-921
31. Weinberger J., Amols H., Ennis R.D., et al. Intracoronary irradiation: dose response for the prevention of restenosis in swine. Int J Radiat Oncol Biol Phys 36 (1996) 767-775
32. Wolfram R., Pocrajac B., Ahmadi R., et al. Endovascular brachytherapy for prophylaxis of restenosis after long segment femoropopliteal stenting. Pilot study. Radiology 220 (2001) 724-729